Idexx Laboratories


IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets. Incorporated in 1983 and headquartered in Westbrook, Maine, and EMEA in Hoofddorp, Netherlands,
IDEXX offers products to customers in over 175 countries around the world and employs over 7,000 people in full-and part-time positions. There are three main segments of the company: Companion Animal Group, Water, and Livestock, Poultry and Dairy. In addition, the company also manufactures and sells pet-side SNAP tests for a variety of animal health diagnostic uses.

Products & Services

Companion Animal Group

The Companion Animal Group provides in-clinic laboratory analyzers for companion animals. Analyzers measure blood cell counts as well as levels of certain enzymes in blood or urine for the purpose of monitoring health conditions. Major products of this segment are the Catalyst Dx Chemistry Analyzer and the VetTest Chemistry Analyzer, Symmetric dimethylarginine, ProCyte Dx Hematology Analyzer, the LaserCyte Hematology Analyzer, the IDEXX VetAutoread Hematology Analyzer, the SNAP Pro analyzer, and so on, among other laboratory equipment and analytical services. Other areas of the CAG division are centered on diagnostic imaging and veterinary practice management software systems, including the flagship program Cornerstone, as well as DVMax, Animana and several legacy practice management software systems.

Water testing

The Water segment provides products to measure microbiological parameters in water. Products of this segment include the Colilert, Colilert-18, and Colisure tests. Water products are sold in over 120 countries around the globe.

Livestock and Poultry Diagnostics

The Livestock and Poultry Diagnostics division provides products to detect diseases in livestock and poultry. Products of this segment include tests for Avian Influenza, Bovine Viral Diarrhoea Virus, Porcine Reproductive and Respiratory Syndrome, and Bovine Spongiform Encephalopathy.

Stock Performance

IDEXX is a publicly traded stock and ended 2019 with a market cap of $22.40Bn and share price of $261.13.